These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 24767373

  • 1. Expression pattern analysis of hepatocellular carcinoma tumor markers in viral hepatitis B and C patients undergoing liver transplantation and resection.
    Ha TY, Hwang S, Kim KH, Lee YJ, Ahn CS, Moon DB, Song GW, Park KM, Kim N, Lee SG.
    Transplant Proc; 2014 Apr; 46(3):888-93. PubMed ID: 24767373
    [Abstract] [Full Text] [Related]

  • 2. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS, Park JW, Jang JS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.
    J Clin Gastroenterol; 2009 Apr; 43(5):482-8. PubMed ID: 19197197
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.
    Seo SI, Kim HS, Kim WJ, Shin WG, Kim DJ, Kim KH, Jang MK, Lee JH, Kim JS, Kim HY, Kim DJ, Lee MS, Park CK.
    World J Gastroenterol; 2015 Apr 07; 21(13):3928-35. PubMed ID: 25852278
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
    Peng YC, Chan CS, Chen GH.
    Hepatogastroenterology; 1999 Apr 07; 46(30):3208-11. PubMed ID: 10626187
    [Abstract] [Full Text] [Related]

  • 8. Differential impact of risk factors for tumor recurrence in hepatitis B and hepatitis C virus-infected patients undergoing liver transplantation for hepatocellular carcinoma.
    Krasnodębski M, Grąt M, Masior Ł, Patkowski W, Krawczyk M.
    Ann Transplant; 2015 Feb 02; 20():70-5. PubMed ID: 25639825
    [Abstract] [Full Text] [Related]

  • 9. Role of serum prothrombin induced by vitamin K absence or antagonist-II in the early detection of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Yoon YJ, Han KH, Kim DY.
    Scand J Gastroenterol; 2009 Feb 02; 44(7):861-6. PubMed ID: 19391065
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Optimal cut-off value of PIVKA-II for diagnosis of hepatocellular carcinoma--using ROC curve].
    Kim MJ, Bae KW, Seo PJ, Jeong IK, Kim JH, Lee BH, Bang KT, Kim DW, Song IH.
    Korean J Hepatol; 2006 Sep 02; 12(3):404-11. PubMed ID: 16998292
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. α-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation.
    Zhang Q, Shang L, Zang Y, Chen X, Zhang L, Wang Y, Wang L, Liu Y, Mao S, Shen Z.
    Eur J Gastroenterol Hepatol; 2014 May 02; 26(5):544-52. PubMed ID: 24614696
    [Abstract] [Full Text] [Related]

  • 14. Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II.
    Yano Y, Yamashita F, Kuwaki K, Fukumori K, Kato O, Yamamoto H, Ando E, Tanaka M, Sata M.
    Liver Int; 2006 Sep 02; 26(7):789-95. PubMed ID: 16911460
    [Abstract] [Full Text] [Related]

  • 15. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B, Alshebeeb K, Tabrizian P, Marti J, Pierobon ES, Lubezky N, Roayaie S, Florman S, Schwartz ME.
    Ann Surg; 2014 Oct 02; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [Abstract] [Full Text] [Related]

  • 16. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.
    Scand J Gastroenterol; 2008 Oct 02; 43(7):849-56. PubMed ID: 18584524
    [Abstract] [Full Text] [Related]

  • 17. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
    Xuan SY, Xin YN, Chen H, Shi GJ, Guan HS, Li Y.
    World J Gastroenterol; 2007 Mar 28; 13(12):1870-4. PubMed ID: 17465484
    [Abstract] [Full Text] [Related]

  • 18. Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma.
    Iizuka N, Sakaida I, Moribe T, Fujita N, Miura T, Stark M, Tamatsukuri S, Ishitsuka H, Uchida K, Terai S, Sakamoto K, Tamesa T, Oka M.
    Anticancer Res; 2006 Mar 28; 26(6C):4713-9. PubMed ID: 17214331
    [Abstract] [Full Text] [Related]

  • 19. Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma.
    Tanaka Y, Kashiwagi T, Tsutsumi H, Nagasawa M, Toyama T, Ozaki S, Naito M, Ishibashi K, Azuma M.
    Hepatogastroenterology; 1999 Mar 28; 46(28):2464-8. PubMed ID: 10522021
    [Abstract] [Full Text] [Related]

  • 20. Liver Transplantation for Non-B and Non-C Hepatocellular Carcinoma.
    Kaido T, Mori A, Ogura Y, Hata K, Yoshizawa A, lida T, Yagi S, Uemoto S.
    Hepatogastroenterology; 2015 Jun 28; 62(140):933-6. PubMed ID: 26902031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.